NEW TREATMENTS FOR PATIENTS WITH MENTAL ILLNESS
Associate Professor Bernadette Fitzgibbon
Director of Psychiatry Research
Paratus Clinical, Australia &
Associate Professor,
Australian National University, Canberra, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | November 2025
Associate Professor Bernadette Fitzgibbon is a neuroscientist with several decades of experience in researching, developing, and translating novel therapies for mental health and chronic pain conditions. This includes the application and optimisation of brain stimulation and psychedelic therapies, overseeing large multi-site intervention trials, both within Australia and abroad. Through her work, she has developed meaningful collaborations with consumers, volunteers, policy makers, and services providers, ensuring that the outcomes of her work contribute towards real-world clinical impact.
She is currently the Director of Psychiatry Research at Paratus Clinical, where she leads the delivery of clinical trials in emerging therapies for psychiatry, collaborating with academic institutions, pharmaceutical and biotechnology companies. She is also an Associate Professor at the Australian National University, where she contributes to novel investigator-initiated trials within interventional psychiatry and clinical neuroscience, and a consultant at The Psychedelic Consultancy: a hub to connect and support professionals navigate the legal psychedelic assisted psychotherapy ecosystem in Australia and internationally. Together, she is dedicated to changing the landscape of mental health treatments to improve the outcomes for people living with mental illness.
Source: Supplied
https://orcid.org/0000-0002-5339-5304
-
Enhancing occupational therapy service provision with military veterans
Prof McKinstry was instrumental in the development of the occupational therapy course at the La Trobe University’s Bendigo campus and also the establishment of the Rural Health School.
Prof McKinstry’s research focus is on health workforce, particularly developing a sustainable rural health workforce through recruitment of rural students for health courses, innovative and flexible delivery of health courses, telehealth and emerging areas of practice for occupational therapists.
-
Genetic disease research imitating function and architecture of organs
Professor Wolvetang was among the first to bring the first human embryonic stem cells to Queensland, with his Wolvetang Group at the AIBN now renowned for its work with organoids: growing them, studying them, and using them to try and understand diseases and human development.
Using cutting edge technology, Professor Wolvetang designs and grows organoids both for their own work and for labs across the country, coaxing pluripotent stem cells or tissue samples into 3D structures that mimic the function and architecture of real brains, livers, kidneys, spinal cords, and intestines.
-
Discovery of RANK Ligand’s role in bone metabolism and the immune system to treat osteoporosis
Emeritus Professor Jack Martin’s research began a discovery cascade that led to the identification of a new protein and the development of a novel and effective drug therapy that is now used worldwide to treat osteoporosis, cancer and other diseases.
